Literature DB >> 22898729

Reporting of subgroup analyses from clinical trials.

Maria Pia Sormani, Paolo Bruzzi.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22898729     DOI： 10.1016/S1474-4422(12)70181-3

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN： 1474-4422            Impact factor:   44.182


× No keyword cloud information.
  3 in total

1.  The Use of Not-Negative Conclusions to Describe Results of Formally Negative Trials Presented at Oncology Meetings.

Authors:  Massimo Di Maio; Marco Audisio; Claudia Cardone; Emmanuele De Luca; Piera Gargiulo; Clizia Zichi; Francesco Perrone
Journal:  JAMA Oncol       Date:  2020-06-01       Impact factor: 31.777

2.  Improving the quality of adult mortality data collected in demographic surveys: validation study of a new siblings' survival questionnaire in Niakhar, Senegal.

Authors:  Stéphane Helleringer; Gilles Pison; Bruno Masquelier; Almamy Malick Kanté; Laetitia Douillot; Géraldine Duthé; Cheikh Sokhna; Valérie Delaunay
Journal:  PLoS Med       Date:  2014-05-27       Impact factor: 11.069

3.  Interpreting the results of a retrospective comparison of test and reference treatments in a randomized clinical trial setting.

Authors:  Moshe Fridman; M Haim Erder
Journal:  Clin Drug Investig       Date:  2015-02       Impact factor: 2.859
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.